Schulte M, Hochmuth K, Steadham E, Lonergan S, Hansen S, Huff-Lonergan E
J Anim Sci. 2024; 102.
PMID: 39279203
PMC: 11491740.
DOI: 10.1093/jas/skae272.
Hilgers R, Das K
Antioxid Redox Signal. 2024; 41(13-15):818-844.
PMID: 39099341
PMC: 11631806.
DOI: 10.1089/ars.2023.0416.
Masood S, Kim H, Pennington E, Tallman K, Porter N, Bromberg P
Redox Biol. 2024; 73:103199.
PMID: 38810423
PMC: 11167385.
DOI: 10.1016/j.redox.2024.103199.
Jezek P, Dlaskova A, Engstova H, Spackova J, Tauber J, Pruchova P
Physiol Res. 2024; 73(S1):S217-S242.
PMID: 38647168
PMC: 11412358.
DOI: 10.33549/physiolres.935269.
Chen Z, Lin J, Wang H, Wang J, Zhang Z
J Int Med Res. 2024; 52(3):3000605241236276.
PMID: 38506348
PMC: 10956161.
DOI: 10.1177/03000605241236276.
Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expression.
Chua P, Ow S, Ng C, Huang W, Low J, Tan P
Cancer Cell Int. 2024; 24(1):59.
PMID: 38321552
PMC: 10845805.
DOI: 10.1186/s12935-024-03248-x.
Exploring the role of PRDX4 in the development of uterine corpus endometrial carcinoma.
Lei P, Yu L, Sun X, Hao J, Shi W, Sun H
Med Oncol. 2024; 41(2):48.
PMID: 38177789
DOI: 10.1007/s12032-023-02265-6.
Comparative Analysis of Inhibitor Binding to Peroxiredoxins from Candidatus Liberibacter asiaticus and Its Host Citrus sinensis.
Gupta D, Lonare S, Rani R, Singh A, Ghosh D, Tomar S
Appl Biochem Biotechnol. 2023; 196(8):5334-5353.
PMID: 38157153
DOI: 10.1007/s12010-023-04798-y.
Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases.
Korczowska-Lacka I, Slowikowski B, Piekut T, Hurla M, Banaszek N, Szymanowicz O
Antioxidants (Basel). 2023; 12(10).
PMID: 37891890
PMC: 10604347.
DOI: 10.3390/antiox12101811.
Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases.
Cui S, Ghai A, Deng Y, Li S, Zhang R, Egbulefu C
Mol Cell. 2023; 83(21):3931-3939.e5.
PMID: 37863053
PMC: 10841858.
DOI: 10.1016/j.molcel.2023.09.025.
Pitfalls of Mitochondrial Redox Signaling Research.
Jezek P
Antioxidants (Basel). 2023; 12(9).
PMID: 37759999
PMC: 10525995.
DOI: 10.3390/antiox12091696.
Peroxiredoxin 5 regulates osteogenic differentiation through interaction with hnRNPK during bone regeneration.
Cho E, Che X, Ang M, Cheon S, Lee J, Kim K
Elife. 2023; 12.
PMID: 36735291
PMC: 9897727.
DOI: 10.7554/eLife.80122.
Association of SRXN1 Receptor Gene Polymorphism with Susceptibility to Periodontitis.
Murthykumar K, Varghese S, Jayaseelan V
Contemp Clin Dent. 2023; 13(4):363-368.
PMID: 36686993
PMC: 9855261.
DOI: 10.4103/ccd.ccd_309_21.
The Role of Oxidative Inactivation of Phosphatase PTEN and TCPTP in Fatty Liver Disease.
Huu T, Park J, Zhang Y, Thanh H, Park I, Choi J
Antioxidants (Basel). 2023; 12(1).
PMID: 36670982
PMC: 9854873.
DOI: 10.3390/antiox12010120.
Molecular characterization and functional analysis of peroxiredoxin 3 (NdPrx3) from .
Xu C, Wang Y, Zhang R, Zhang J, Sun Y
Fish Shellfish Immunol Rep. 2023; 4:100081.
PMID: 36654784
PMC: 9841174.
DOI: 10.1016/j.fsirep.2023.100081.
Essential Roles of Peroxiredoxin IV in Inflammation and Cancer.
Thapa P, Ding N, Hao Y, Alshahrani A, Jiang H, Wei Q
Molecules. 2022; 27(19).
PMID: 36235049
PMC: 9573489.
DOI: 10.3390/molecules27196513.
PRDX6 knockout restrains the malignant progression of intrahepatic cholangiocarcinoma.
Li H, Wu Z, Zhong R, Zhang Q, Chen Q, Shen Y
Med Oncol. 2022; 39(12):250.
PMID: 36209344
PMC: 9547796.
DOI: 10.1007/s12032-022-01822-9.
Regulatory mechanisms of tetramethylpyrazine on central nervous system diseases: A review.
Liu Y, Yang G, Cui W, Zhang Y, Liang X
Front Pharmacol. 2022; 13:948600.
PMID: 36133805
PMC: 9483103.
DOI: 10.3389/fphar.2022.948600.
18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs.
Zhang Q, Luo P, Zheng L, Chen J, Zhang J, Tang H
J Pharm Anal. 2022; 12(4):570-582.
PMID: 36105163
PMC: 9463498.
DOI: 10.1016/j.jpha.2022.06.001.
ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance.
Stieg D, Wang Y, Liu L, Jiang B
Int J Mol Sci. 2022; 23(12).
PMID: 35743145
PMC: 9223852.
DOI: 10.3390/ijms23126702.